PCSA
Processa Pharmaceuticals, Inc.Company with tickers: PCSA
CIK
1533743
CUSIP
74275C403
Shares Outstanding
2,750,173
13F Activity (30d)
6 filings
6 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-3,331,214 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-3,377,179 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-1.29 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-1.29 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |